PT1305020E - Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva - Google Patents

Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva

Info

Publication number
PT1305020E
PT1305020E PT01955528T PT01955528T PT1305020E PT 1305020 E PT1305020 E PT 1305020E PT 01955528 T PT01955528 T PT 01955528T PT 01955528 T PT01955528 T PT 01955528T PT 1305020 E PT1305020 E PT 1305020E
Authority
PT
Portugal
Prior art keywords
fibrates
preparation
treatment
medicinal product
cardiac insufficiency
Prior art date
Application number
PT01955528T
Other languages
English (en)
Inventor
Arduini Arduino
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of PT1305020E publication Critical patent/PT1305020E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01955528T 2000-08-01 2001-07-20 Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva PT1305020E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000433A IT1317885B1 (it) 2000-08-01 2000-08-01 Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.

Publications (1)

Publication Number Publication Date
PT1305020E true PT1305020E (pt) 2006-10-31

Family

ID=11454866

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01955528T PT1305020E (pt) 2000-08-01 2001-07-20 Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva

Country Status (18)

Country Link
US (2) US20030176499A1 (pt)
EP (1) EP1305020B1 (pt)
JP (1) JP2004505037A (pt)
KR (1) KR100844190B1 (pt)
CN (1) CN1798554A (pt)
AT (1) ATE330597T1 (pt)
AU (2) AU7768601A (pt)
BR (1) BR0112874A (pt)
CA (1) CA2415042C (pt)
CY (1) CY1106318T1 (pt)
DE (1) DE60120985T2 (pt)
ES (1) ES2267796T3 (pt)
IT (1) IT1317885B1 (pt)
MX (1) MXPA03000900A (pt)
PL (1) PL365040A1 (pt)
PT (1) PT1305020E (pt)
SK (1) SK287410B6 (pt)
WO (1) WO2002009682A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481371A1 (en) * 2002-03-11 2003-09-18 Peter Zahradka Use of ppar alpha agonists for the treatment of vascular and renal diseases
CN100347262C (zh) * 2003-11-13 2007-11-07 同济大学 一种水溶性建筑粘结剂及其制备方法
JP5317919B2 (ja) * 2009-10-05 2013-10-16 花王株式会社 Gip上昇抑制剤の評価又は選択方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR208203A1 (es) * 1974-09-10 1976-12-09 Cortial Proceso para la preparacion de acido p-trialquilsilil benzoico y derivados del mismo
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US4463013A (en) * 1982-04-09 1984-07-31 The Upjohn Company Oxygen substituted amino-cyclohexyl-benzeneacetamides and -benzamides as water diuretic drugs
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker
WO1998005331A2 (en) * 1996-08-02 1998-02-12 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
AU8182198A (en) * 1997-07-22 1999-02-16 Olin Corporation Copper alloy having magnesium addition
IT1299266B1 (it) * 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
PE20011010A1 (es) * 1999-12-02 2001-10-18 Glaxo Group Ltd Oxazoles y tiazoles sustituidos como agonista del receptor activado por el proliferador de peroxisomas humano
GB0002667D0 (en) * 2000-02-04 2000-03-29 Glaxo Group Ltd medicamesnts
US7352911B2 (en) * 2003-07-31 2008-04-01 Hewlett-Packard Development Company, L.P. Method for bilateral filtering of digital images

Also Published As

Publication number Publication date
EP1305020B1 (en) 2006-06-21
CY1106318T1 (el) 2011-10-12
JP2004505037A (ja) 2004-02-19
AU7768601A (en) 2002-02-13
IT1317885B1 (it) 2003-07-15
US20090221701A1 (en) 2009-09-03
KR100844190B1 (ko) 2008-07-04
EP1305020A2 (en) 2003-05-02
ES2267796T3 (es) 2007-03-16
BR0112874A (pt) 2003-07-01
MXPA03000900A (es) 2003-10-06
ITRM20000433A0 (it) 2000-08-01
WO2002009682A3 (en) 2002-04-18
KR20030041953A (ko) 2003-05-27
ATE330597T1 (de) 2006-07-15
DE60120985T2 (de) 2006-12-21
WO2002009682A2 (en) 2002-02-07
CA2415042A1 (en) 2002-02-07
SK287410B6 (sk) 2010-09-07
PL365040A1 (en) 2004-12-27
US20030176499A1 (en) 2003-09-18
ITRM20000433A1 (it) 2002-02-01
CN1798554A (zh) 2006-07-05
DE60120985D1 (de) 2006-08-03
CA2415042C (en) 2009-06-23
AU2001277686B2 (en) 2006-07-20
SK1312003A3 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
UA74346C2 (uk) Похідні амінодикарбонових кислот, їх застосування та лікарський засіб
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
EA200400481A1 (ru) Применение флибансерина для лечения половых расстройств
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
BR0112591A (pt) Derivados de acridina e sua aplicação como medicamento
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
TR200200648T2 (tr) Farmasötik özelliklere sahip yeni dikarboksilik asit türevleri.
BR0015188A (pt) Composições farmacêuticas
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0013924A (pt) Soluções farmacêuticas de levosimendano
WO2002030867A3 (en) Drugs for diabetes
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
ATE360428T1 (de) Analgetisches arzneimittel
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
PT1305020E (pt) Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva
ES2191206T3 (es) Nueva utilizacion de la creatina.
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
CY1116171T1 (el) Χρηση ακετυλο-l-καρνιτινης για την παρασκευη φαρμακου για τη θεραπευτικη αγωγη του νευροπαθητικου πονου σε διαβητικους ασθενεις
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
HK1075006A1 (en) Use of spirolaxine for the preparation of a medicament treating type 2 insulin-resistant diabetes mellitus
AR035986A1 (es) Uso de derivados anti-convulsivos para la manufactura de un medicamento util para el tratamiento del temblor esencial